These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 23293303)

  • 41. Depressive symptoms are common and associated with adverse clinical outcomes in heart failure with reduced and preserved ejection fraction.
    Kato N; Kinugawa K; Shiga T; Hatano M; Takeda N; Imai Y; Watanabe M; Yao A; Hirata Y; Kazuma K; Nagai R
    J Cardiol; 2012 Jul; 60(1):23-30. PubMed ID: 22445598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Global variation in clinical profile, management, and post-discharge outcomes among patients hospitalized for worsening chronic heart failure: findings from the ASTRONAUT trial.
    Greene SJ; Fonarow GC; Solomon SD; Subacius H; Maggioni AP; Böhm M; Lewis EF; Zannad F; Gheorghiade M;
    Eur J Heart Fail; 2015 Jun; 17(6):591-600. PubMed ID: 25930208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function.
    Weatherley BD; Cotter G; Dittrich HC; DeLucca P; Mansoor GA; Bloomfield DM; Ponikowski P; O'Connor CM; Metra M; Massie BM;
    J Card Fail; 2010 Jan; 16(1):25-35. PubMed ID: 20123315
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
    Olsson LG; Swedberg K; Ducharme A; Granger CB; Michelson EL; McMurray JJ; Puu M; Yusuf S; Pfeffer MA;
    J Am Coll Cardiol; 2006 May; 47(10):1997-2004. PubMed ID: 16697316
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Home-based telemonitoring of simple vital signs to reduce hospitalization in heart failure patients: real-world data from a community-based hospital].
    Palmieri V; Pezzullo S; Lubrano V; Bettella S; Olandese M; Sorrentino C; Russo C; Celentano A
    G Ital Cardiol (Rome); 2011 Dec; 12(12):829-36. PubMed ID: 22158454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
    J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
    Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K;
    Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Novel In-hospital Congestion Score to Risk Stratify Patients Admitted for Worsening Heart Failure (from ASCEND-HF).
    Masson R; Ambrosy AP; Kheder K; Fudim M; Clare RM; Coles A; Hernandez AF; Starling RC; Ezekowitz JA; O'Connor CM; Mentz RJ
    J Cardiovasc Transl Res; 2020 Aug; 13(4):540-548. PubMed ID: 31933144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure.
    Michtalik HJ; Yeh HC; Campbell CY; Haq N; Park H; Clarke W; Brotman DJ
    Am J Cardiol; 2011 Apr; 107(8):1191-5. PubMed ID: 21296322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic value of monocyte count in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial).
    Greene SJ; Harinstein ME; Vaduganathan M; Subačius H; Konstam MA; Zannad F; Maggioni AP; Swedberg K; Butler J; Gheorghiade M;
    Am J Cardiol; 2012 Dec; 110(11):1657-62. PubMed ID: 22917555
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug and device effects on peak oxygen consumption, 6-minute walk distance, and natriuretic peptides as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction.
    Wessler BS; Kramer DG; Kelly JL; Trikalinos TA; Kent DM; Konstam MA; Udelson JE
    Circ Heart Fail; 2011 Sep; 4(5):578-88. PubMed ID: 21705485
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
    Cohen-Solal A; Logeart D; Huang B; Cai D; Nieminen MS; Mebazaa A
    J Am Coll Cardiol; 2009 Jun; 53(25):2343-8. PubMed ID: 19539144
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Poor in-hospital congestion improvement in acute heart failure patients classified according to left ventricular ejection fraction: prognostic implications.
    Ruocco G; Girerd N; Rastogi T; Lamiral Z; Palazzuoli A
    Eur Heart J Cardiovasc Imaging; 2024 Jul; 25(8):1127-1135. PubMed ID: 38478596
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Readmission and death after an acute heart failure event: predictors and outcomes in sub-Saharan Africa: results from the THESUS-HF registry.
    Sliwa K; Davison BA; Mayosi BM; Damasceno A; Sani M; Ogah OS; Mondo C; Ojji D; Dzudie A; Kouam Kouam C; Suliman A; Schrueder N; Yonga G; Ba SA; Maru F; Alemayehu B; Edwards C; Cotter G
    Eur Heart J; 2013 Oct; 34(40):3151-9. PubMed ID: 24048728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of soluble glycoprotein 130 and cardiac natriuretic peptides as long-term predictors of heart failure progression.
    Gwechenberger M; Pacher R; Berger R; Zorn G; Moser P; Stanek B; Huelsmann M
    J Heart Lung Transplant; 2005 Dec; 24(12):2190-5. PubMed ID: 16364870
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heart failure in patients with preserved and deteriorated left ventricular ejection fraction.
    Varela-Roman A; Grigorian L; Barge E; Bassante P; de la Peña MG; Gonzalez-Juanatey JR
    Heart; 2005 Apr; 91(4):489-94. PubMed ID: 15772209
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.
    Maisel A; Hollander JE; Guss D; McCullough P; Nowak R; Green G; Saltzberg M; Ellison SR; Bhalla MA; Bhalla V; Clopton P; Jesse R;
    J Am Coll Cardiol; 2004 Sep; 44(6):1328-33. PubMed ID: 15364340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
    Fonarow GC; Stough WG; Abraham WT; Albert NM; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
    J Am Coll Cardiol; 2007 Aug; 50(8):768-77. PubMed ID: 17707182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure.
    Rubio-Gracia J; Demissei BG; Ter Maaten JM; Cleland JG; O'Connor CM; Metra M; Ponikowski P; Teerlink JR; Cotter G; Davison BA; Givertz MM; Bloomfield DM; Dittrich H; Damman K; Pérez-Calvo JI; Voors AA
    Int J Cardiol; 2018 May; 258():185-191. PubMed ID: 29544928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.